FindTrial
Sign In

To study sensitivity of a blood test to detect cancer cells in human blood for early diagnosis of cancer.

An observational clinical trial with case control cross sectional study design to test the sensitivity of a proprietary polymeric-antibody system designed to capture and concentrate circulating tumor cells (CTCs) in blood samples of patients with certain carcinomas. - SENCTC

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/06/006985
Enrollment
100
Registered
2016-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Breast, Colorectal, Lung, Cervix Uteri, Prostate, Stomach and Head & Neck Cancer

Interventions

None listed

Sponsors

Actorius Innovations and Research Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Written informed consent. 2. Confirmed diagnosis of stage 2-4 breast, lung, colorectal cervix uteri, prostate, stomach and head & neck cancer, (OR) no prior history of cancer. 3. Stage 2-4 treatment naive, metastatic, secondary, and recurrent cancer patients. 4. Able to undergo blood collection prior to initiation of chemotherapy treatment, (OR) able to provide blood sample if subject is a non-cancer control subject.

Exclusion criteria

Exclusion criteria: 1. Patients unable to understand the research protocol and/or provide informed consent. 2. Patients with known immunodeficiency, or pregnancy.

Design outcomes

Primary

MeasureTime frame
The number of circulating tumor cells (CTCs) per milliliter of whole blood. Reported unit of measure will be the number of CTCs/milliliter. Timepoint: Blood samples will be collected from study subjects at a single timepoint and analyzed for the number of circulating tumor cells (CTCs) within 7 days (168 Hrs) of blood collection.—

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable—

Countries

India

Contacts

Public ContactAravindan Vasudevan

Actorius Innovations and Research Pvt Ltd

jayant@actorius.co.in9920526627

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026